Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D E Parratt

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2010
Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytesJohn D E Parratt, John W Prineas
Annals of Neurology|July 26, 2012
Oligodendrocytes and the early multiple sclerosis lesionJohn W Prineas, John D E Parratt
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2017
Multiple sclerosis: Serum anti-CNS autoantibodiesJohn W Prineas, John D E Parratt
Journal of Neuropathology and Experimental Neurology|September 23, 2021
Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated DemyelinationJohn W Prineas, John D E Parratt
Journal of Neuropathology and Experimental Neurology|July 23, 2016
Fibrosis of the Choroid Plexus Filtration MembraneJohn W Prineas, John D E Parratt, Paul D Kirwan
Case Reports in Neurological Medicine|June 23, 2020
The Successful Use of Infliximab in a Relapsing Case of Susac's SyndromeSuran L Fernando, Therese Boyle, Annika Smith, et al.
Annals of Neurology|February 6, 2009
Immunoglobulins and complement in postmortem multiple sclerosis tissueMichael H Barnett, John D E Parratt, Eun-Sook Cho, et al.
Annals of Neurology|December 26, 2009
Multiple sclerosis: distribution of inflammatory cells in newly forming lesionsAndrew P D Henderson, Michael H Barnett, John D E Parratt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 28, 2025
Evolution of Chronic Lesion Tissue in Relapsing-Remitting Patients With Multiple Sclerosis: An Association With Disease ProgressionSamuel Klistorner, Michael Barnett, John D E Parratt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 18, 2021
Interferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MSYuyi You, Michael H Barnett, Con Yiannikas, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2010
Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytesJohn D E Parratt, John W Prineas
Annals of Neurology|July 26, 2012
Oligodendrocytes and the early multiple sclerosis lesionJohn W Prineas, John D E Parratt
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2017
Multiple sclerosis: Serum anti-CNS autoantibodiesJohn W Prineas, John D E Parratt
Journal of Neuropathology and Experimental Neurology|September 23, 2021
Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated DemyelinationJohn W Prineas, John D E Parratt
Journal of Neuropathology and Experimental Neurology|July 23, 2016
Fibrosis of the Choroid Plexus Filtration MembraneJohn W Prineas, John D E Parratt, Paul D Kirwan
Case Reports in Neurological Medicine|June 23, 2020
The Successful Use of Infliximab in a Relapsing Case of Susac's SyndromeSuran L Fernando, Therese Boyle, Annika Smith, et al.
Annals of Neurology|February 6, 2009
Immunoglobulins and complement in postmortem multiple sclerosis tissueMichael H Barnett, John D E Parratt, Eun-Sook Cho, et al.
Annals of Neurology|December 26, 2009
Multiple sclerosis: distribution of inflammatory cells in newly forming lesionsAndrew P D Henderson, Michael H Barnett, John D E Parratt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 28, 2025
Evolution of Chronic Lesion Tissue in Relapsing-Remitting Patients With Multiple Sclerosis: An Association With Disease ProgressionSamuel Klistorner, Michael Barnett, John D E Parratt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 18, 2021
Interferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MSYuyi You, Michael H Barnett, Con Yiannikas, et al.
Pageof 2